Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for SCI Pharmtech, Inc. (4119.TW), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
111.40
P/B ratioShare price divided by book value per share.
1.25
P/S ratioMarket value divided by annual revenue.
5.28
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
21.54
EV / RevenueEnterprise value against annual revenue.
6.04
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
0.90%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
24.21%
Operating marginRevenue left after operating costs.
3.42%
Net marginRevenue left after every cost, including tax and interest.
4.77%
Return on equityProfit as a percentage of shareholders’ equity.
1.12%
Return on assetsProfit as a percentage of total assets.
0.93%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.25
Quick ratioThe same, excluding inventory.
0.33
Debt to equityTotal borrowings against shareholders’ equity.
0.20
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.50
Book value per shareShareholders’ equity divided by shares outstanding.
$44.44
Shares outstandingShares currently issued.
119,508,634
Market capitalisationShare price times shares outstanding.
$6.66B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.35%
Payout ratioShare of profit paid out as dividends.
150.39%
SCI Pharmtech, Inc. (4119.TW) statistics — frequently asked questions
What is SCI Pharmtech, Inc.'s P/E ratio?
SCI Pharmtech, Inc. (4119.TW) trades on a price-to-earnings ratio of 111.40.
What is SCI Pharmtech, Inc.'s return on equity?
SCI Pharmtech, Inc. (4119.TW) reports a return on equity of 1.12%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does SCI Pharmtech, Inc. carry?
SCI Pharmtech, Inc. (4119.TW) has a debt-to-equity ratio of 0.20, which compares total borrowings with shareholders' equity.
What is SCI Pharmtech, Inc.'s profit margin?
SCI Pharmtech, Inc. (4119.TW) keeps 4.77% of revenue as net profit after every cost, including tax and interest.